<bill session="115" type="h" number="1776" updated="2017-08-02T18:15:38Z">
  <state datetime="2017-03-29">REFERRED</state>
  <status>
    <introduced datetime="2017-03-29"/>
  </status>
  <introduced datetime="2017-03-29"/>
  <titles>
    <title type="short" as="introduced">Improving Access To Affordable Prescription Drugs Act</title>
    <title type="short" as="introduced">Improving Access To Affordable Prescription Drugs Act</title>
    <title type="official" as="introduced">To improve access to affordable prescription drugs.</title>
    <title type="display">Improving Access To Affordable Prescription Drugs Act</title>
  </titles>
  <sponsor id="400360"/>
  <cosponsors>
    <cosponsor id="412687" joined="2017-04-25"/>
    <cosponsor id="412379" joined="2017-06-06"/>
    <cosponsor id="412236" joined="2017-06-23"/>
    <cosponsor id="400080" joined="2017-04-06"/>
    <cosponsor id="400090" joined="2017-03-29"/>
    <cosponsor id="400103" joined="2017-03-29"/>
    <cosponsor id="412215" joined="2017-04-25"/>
    <cosponsor id="400162" joined="2017-04-05"/>
    <cosponsor id="400259" joined="2017-07-26"/>
    <cosponsor id="408211" joined="2017-05-18"/>
    <cosponsor id="400316" joined="2017-04-06"/>
    <cosponsor id="412307" joined="2017-05-18"/>
    <cosponsor id="412585" joined="2017-04-05"/>
    <cosponsor id="400350" joined="2017-05-16"/>
    <cosponsor id="412219" joined="2017-04-25"/>
    <cosponsor id="412239" joined="2017-03-29"/>
  </cosponsors>
  <actions>
    <action datetime="2017-03-29">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-03-29" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-03-29">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2017-03-29">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2017-03-29">
      <text>Referred to House Judiciary</text>
    </action>
    <action datetime="2017-03-31">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSJU" name="House Judiciary" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="115" type="s" number="252"/>
    <bill relation="unknown" session="115" type="s" number="348"/>
    <bill relation="unknown" session="115" type="s" number="469"/>
    <bill relation="identical" session="115" type="s" number="771"/>
    <bill relation="unknown" session="115" type="h" number="1245"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Administrative remedies"/>
    <term name="Business records"/>
    <term name="Canada"/>
    <term name="Cancer"/>
    <term name="Civil actions and liability"/>
    <term name="Competition and antitrust"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Corporate finance and management"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Executive agency funding and structure"/>
    <term name="Federal Trade Commission (FTC)"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Government trust funds"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health programs administration and funding"/>
    <term name="Income tax deductions"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Inflation and prices"/>
    <term name="Judicial review and appeals"/>
    <term name="Licensing and registrations"/>
    <term name="Marketing and advertising"/>
    <term name="Medicaid"/>
    <term name="Medical research"/>
    <term name="Medicare"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Research and development"/>
    <term name="Retail and wholesale trades"/>
    <term name="Trade restrictions"/>
    <term name="User charges and fees"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
